Literature DB >> 10627868

Hyperphenylalaninaemia in children with falciparum malaria.

C O Enwonwu1, B M Afolabi, L A Salako, E O Idigbe, H al-Hassan, R A Rabiu.   

Abstract

Brain monoamine levels may underlie aspects of the cerebral component of falciparum malaria. Since circulating amino acids are the precursors for brain monoamine synthesis, we measured them in malaria patients and controls. Malaria elicited significantly elevated plasma levels of phenylalanine, particularly in comatose patients, with the Tyr/Phe (%) ratio reduced from 83.3 in controls to 39.5 in infected children, suggesting an impaired phenylalanine hydroxylase enzyme system in malaria infection. Malaria significantly increased the apparent K(m) for Trp, Tyr and His, with no effect on K(m)(app) for Phe. Using the kinetic parameters of NAA transport at the human blood-brain barrier, malaria significantly altered brain uptake of Phe (+96%), Trp (-28%) and His (+31%), with no effect on Tyr (-8%), compared with control findings. Our data suggest impaired cerebral synthesis of serotonin, dopamine and norepinephrine, and enhanced production of histamine, in children with severe falciparum malaria.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10627868     DOI: 10.1093/qjmed/92.9.495

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  15 in total

1.  Tetrahydrobiopterin Supplementation Improves Phenylalanine Metabolism in a Murine Model of Severe Malaria.

Authors:  Matthew S Alkaitis; Hans C Ackerman
Journal:  ACS Infect Dis       Date:  2016-09-27       Impact factor: 5.084

2.  Elevated plasma phenylalanine in severe malaria and implications for pathophysiology of neurological complications.

Authors:  Bert K Lopansri; Nicholas M Anstey; Gregory J Stoddard; Esther D Mwaikambo; Craig S Boutlis; Emiliana Tjitra; Helena Maniboey; Maurine R Hobbs; Marc C Levesque; J Brice Weinberg; Donald L Granger
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

Review 3.  Human malarial disease: a consequence of inflammatory cytokine release.

Authors:  Ian A Clark; Alison C Budd; Lisa M Alleva; William B Cowden
Journal:  Malar J       Date:  2006-10-10       Impact factor: 2.979

4.  Metabolic Signature Profiling as a Diagnostic and Prognostic Tool in Pediatric Plasmodium falciparum Malaria.

Authors:  Izabella Surowiec; Judy Orikiiriza; Elisabeth Karlsson; Maria Nelson; Mari Bonde; Patrick Kyamanwa; Ben Karenzi; Sven Bergström; Johan Trygg; Johan Normark
Journal:  Open Forum Infect Dis       Date:  2015-05-04       Impact factor: 3.835

5.  Experimental malaria: the in vitro and in vivo blood pressure paradox.

Authors:  C R Nwokocha; M I Nwokocha; D U Owu; I O Ajayi; A B Ebeigbe
Journal:  Cardiovasc J Afr       Date:  2012-03       Impact factor: 1.167

6.  Decreased Rate of Plasma Arginine Appearance in Murine Malaria May Explain Hypoargininemia in Children With Cerebral Malaria.

Authors:  Matthew S Alkaitis; Honghui Wang; Allison K Ikeda; Carol A Rowley; Ian J C MacCormick; Jessica H Chertow; Oliver Billker; Anthony F Suffredini; David J Roberts; Terrie E Taylor; Karl B Seydel; Hans C Ackerman
Journal:  J Infect Dis       Date:  2016-12-15       Impact factor: 5.226

7.  The role of previously unmeasured organic acids in the pathogenesis of severe malaria.

Authors:  M Trent Herdman; Natthida Sriboonvorakul; Stije J Leopold; Sam Douthwaite; Sanjib Mohanty; M Mahtab Uddin Hassan; Richard J Maude; Hugh W F Kingston; Katherine Plewes; Prakaykaew Charunwatthana; Kamolrat Silamut; Charles J Woodrow; Aniruddha Ghose; Kesinee Chotinavich; Md Amir Hossain; M Abul Faiz; Saroj Mishra; Natchanun Leepipatpiboon; Nicholas J White; Nicholas P J Day; Joel Tarning; Arjen M Dondorp
Journal:  Crit Care       Date:  2015-09-07       Impact factor: 9.097

8.  Host matrix metalloproteinases in cerebral malaria: new kids on the block against blood-brain barrier integrity?

Authors:  Manuela Polimeni; Mauro Prato
Journal:  Fluids Barriers CNS       Date:  2014-01-27

9.  11β-hydroxysteroid dehydrogenase type 1 has no effect on survival during experimental malaria but affects parasitemia in a parasite strain-specific manner.

Authors:  L Vandermosten; C De Geest; S Knoops; G Thijs; K E Chapman; K De Bosscher; G Opdenakker; P E Van den Steen
Journal:  Sci Rep       Date:  2017-10-23       Impact factor: 4.379

10.  Adrenal hormones mediate disease tolerance in malaria.

Authors:  Leen Vandermosten; Thao-Thy Pham; Sofie Knoops; Charlotte De Geest; Natacha Lays; Kristof Van der Molen; Christopher J Kenyon; Manu Verma; Karen E Chapman; Frans Schuit; Karolien De Bosscher; Ghislain Opdenakker; Philippe E Van den Steen
Journal:  Nat Commun       Date:  2018-10-30       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.